Magle Chemoswed Holding AB (publ) (STO:MAGLE)

Market Cap	533.42M
Revenue (ttm)	283.34M
Net Income (ttm)	7.79M
Shares Out	20.52M
EPS (ttm)	0.50
PE Ratio	52.33
Forward PE	12.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	351
Average Volume	1,651
Open	25.20
Previous Close	25.40
Day's Range	25.20 - 26.00
52-Week Range	24.20 - 49.61
Beta	0.49
RSI	42.79
Earnings Date	Aug 1, 2025

About STO:MAGLE

Magle Chemoswed Holding AB (publ), together with its subsidiaries, operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; amantadine sulfate that is used in the treatment of central nervous system disorders; and benserazide hydrochloride, whic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1944
• Employees: 147
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MAGLE

Financial Performance

In 2024, STO:MAGLE's revenue was 240.57 million, an increase of 40.27% compared to the previous year's 171.50 million. Earnings were 11.94 million, a decrease of -1.91%.